Henry P Parkman
Overview
Explore the profile of Henry P Parkman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
243
Citations
5374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rim D, Parkman H
Neurogastroenterol Motil
. 2024 Jul;
36(10):e14868.
PMID: 39051711
Background: The straight leg raise (SLR) maneuver, often performed during esophageal manometry, requires patients to lift their leg(s) to augment intraabdominal pressure (IAP). Diverse techniques have been applied for SLR....
12.
Koch K, Parkman H, Yates K, Van Natta M, Grover M, Farrugia G, et al.
Dig Dis Sci
. 2024 Jun;
69(8):2904-2915.
PMID: 38877334
Aims: To determine vitamin D levels and relationships among symptoms, gastric emptying and gastric myoelectrical activity (GMA) in patients with symptoms of Gp. Methods: 25-hydroxy-vitamin D was measured in patients...
13.
Safarpour D, Stover N, Shprecher D, Hamedani A, Pfeiffer R, Parkman H, et al.
Parkinsonism Relat Disord
. 2024 May;
124:106982.
PMID: 38729797
Background: Gastrointestinal (GI) dysfunction is a common non-motor feature of Parkinson disease (PD). GI symptoms may start years before the onset of motor symptoms and impair quality of life. Robust...
14.
Parkman H, Rim D, Anolik J, Dadparvar S, Maurer A
J Nucl Med Technol
. 2024 Mar;
52(1):3-7.
PMID: 38443105
Glucagonlike peptide-1 (GLP-1) receptor agonists (RAs) are being increasingly used for glycemic control in patients with diabetes and for weight loss and weight management in obese subjects. There has been...
15.
Chikkamenahalli L, Jessen E, Bernard C, Ip W, Breen-Lyles M, Cipriani G, et al.
iScience
. 2024 Feb;
27(3):108991.
PMID: 38384852
Gastrointestinal immune cells, particularly muscularis macrophages (MM) interact with the enteric nervous system and influence gastrointestinal motility. Here we determine the human gastric muscle immunome and its changes in patients...
16.
17.
Hollis E, Murray H, Parkman H
Neurogastroenterol Motil
. 2023 Dec;
36(2):e14725.
PMID: 38062502
Background: Patients with symptoms of gastroparesis (Gp) often reduce food intake in attempt to manage their symptoms. Up to 40% of adults with Gp have been reported to have symptoms...
18.
Fass R, McCallum R, Parkman H
Gastroenterol Hepatol (N Y)
. 2023 Nov;
5(10 Suppl 18):4-16.
PMID: 37967396
The relationship between gastroparesis and GERD is multi-factorial. The delay in gastric emptying associated with gastroparesis can lead to prolonged gastric retention of food that may have a propensity to...
19.
McCallum R, Parkman H, Fass R, Bhandari B, Carlson M, Buck R
Clin Gastroenterol Hepatol
. 2023 Nov;
22(12):2497-2505.e5.
PMID: 37924856
Background & Aims: Metoclopramide nasal spray (MNS) was developed as an alternative to oral metoclopramide. Prior phase 2 studies demonstrated efficacy in reducing symptoms in women, but not men with...
20.
Hasler W, Lee A, Moshiree B, Surjanhata B, Rao S, Parkman H, et al.
Clin Gastroenterol Hepatol
. 2023 Nov;
22(4):867-877.e12.
PMID: 37913936
Background & Aims: Prokinetics have limited effectiveness for treating symptoms of gastroparesis. Thus, alternative or adjunct therapies, such as gastroparesis diets or neuromodulators, are often prescribed. Their therapeutic benefits alone...